RAFAEL
BOTELLA ESTRADA
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta de Hierro (7)
2024
-
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
Australasian Journal of Dermatology
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)
Actas Dermo-Sifiliograficas
-
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population
Australasian Journal of Dermatology, Vol. 64, Núm. 4, pp. e317-e326
-
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
-
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T479-T487